journal cover

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases

Oct 1, 2011

Rebecca DaviesBSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register

Get paper from

Abstract

Past studies have reported conflicting rates of venous thrombotic events (VTEs) in rheumatoid arthritis (RA). The current study aimed to compare (1) the rates of VTEs in patients with RA treated with anti-tumour necrosis factor (anti-TNF) therapy versus those treated with non-biological...read more

Mentioned in this Paper

Remicade
Biological Products
Vinyltriethoxysilane
Etanercept
Veins
Tumor Necrosis Factor Receptor
Rheumatology Specialty
Antibodies, Monoclonal, Humanized
Polyglobin
Monoclonal Antibodies
2
51
Paper Details
References
  • References11
  • Citations28
12
  • References11
  • Citations28
123

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

Annals of the Rheumatic Diseases

Oct 1, 2011

Rebecca DaviesBSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register

PMID: 21784722

DOI: 10.1136/ard.2011.153536

Abstract

Past studies have reported conflicting rates of venous thrombotic events (VTEs) in rheumatoid arthritis (RA). The current study aimed to compare (1) the rates of VTEs in patients with RA treated with anti-tumour necrosis factor (anti-TNF) therapy versus those treated with non-biological...read more

Mentioned in this Paper

Remicade
Biological Products
Vinyltriethoxysilane
Etanercept
Veins
2
51

Related Papers

Paper Details
References
  • References11
  • Citations28
12
  • References11
  • Citations28
123

Get paper from

/papers/venous-thrombotic-events-are-not-increased-in/21784722